Harrison.ai is a clinician-led healthcare artificial intelligence (AI) company rapidly developing and deploying AI solutions to address persistent healthcare challenges.
Harrison.ai's mission is to continuously innovate and commercialise more efficient and affordable healthcare products and services for healthcare providers and patients.
Harrison.ai was founded in 2018 by Aengus Tran and Dimitry Tran. The company is based in Barangaroo, New South Wales, Australia.
Harrison.ai and its partners have pioneered a unique and proven model to rapidly develop, commercialise and deploy accurate and clinically effective AI tools that support clinical diagnosis in a range of medical areas.
Harrison.ai has developed deep artificial intelligence expertise and methodology that, when combined with the clinical expertise and data of medical partners, significantly shortens the path to market for new healthcare AI applications.
Harrison.ai and I-MED Radiology partnered to form Annalise.ai in early 2020 to develop comprehensive solutions across radiology modalities. Annalise.ai's first product, the world's most comprehensive AI clinical decision-support solution for Chest X-Rays, is already in use by more than 350 radiologists each day.
Harrison.ai is backed by Blackbird Ventures, Horizons Ventures, Skip Capital, Sonic Healthcare, I-MED Radiology Network, Ramsay Health Care, and others. The company raised AU$129M ($97M) in Series B round on Nov 30, 2021. This brings Harrison.ai's total funding to AU$158M ($118M) to date.